Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the efficacy and safety of radiotherapy combined with GDP
(gemcitabine, cisplatin, dexamethasone) chemotherapy in stage I/II extranodal natural
killer/T-cell lymphoma patients with unfavorable prognostic factors.